Perfect Snacks, the brand behind the Original Refrigerated Protein Bartm, today announced a new national campaign with ...

AstraZeneca has outlined plans to invest $15 billion in China through 2030, making a broad commitment to the country to enhance its capabilities in areas including cell therapies and radioconjugates.

AstraZeneca is showing no signs of restarting a 200 million pound sterling ($273 million) investment in its U.K. hometown, despite keeping its options open. AstraZeneca paused the investment in its ...

Investment is AstraZeneca's largest to date in China Will enhance cell therapy and radioconjugates capabilities AstraZeneca partners with Chinese biotechs for drug development BEIJING/LONDON, Jan 29 ...

LONDON, Jan 26 (Reuters) - UK-based drugmakers AstraZeneca (AZN.L), opens new tab and GSK (GSK.L), opens new tab will join British Prime Minister Keir Starmer's trip to China this week, sources said, ...

Pharma giant AstraZeneca (AZN) is transitioning its U.S. listing by delisting American Depositary Shares (ADS) from Nasdaq and directly listing its ordinary shares on the New York Stock Exchange (NYSE ...

AstraZeneca AZN1.99%increase; green up pointing triangle said it entered into a collaboration agreement with China’s CSPC Pharmaceuticals to gain rights to a portfolio of early-stage experimental ...

Starmer brings nearly 60 business and cultural groups on first U.K. leader visit to China in eight years. Talks with Xi and Li focus on trade, investment and national security. Visit follows a surge ...

AstraZeneca has announced it's investing $15 billions in China, and said it is partnering with a Chinese biotech to develop weight-loss drugs. The developments come at a critical time for the pharma ...

Add Yahoo as a preferred source to see more of our stories on Google. A company logo is seen at the AstraZeneca site in Macclesfield, Britain, May 11, 2021. REUTERS/Phil Noble Feb 3 (Reuters) - ...